Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label attachment file name title
tabling member	label

Search

1293256

registered interest
date	01/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Admissions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the proportion of people of hospital being treated for (a) covid-19 and (b) other reasons in each region of the UK in each of the last 12 months.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	160659
answer	answer is ministerial correction date of answer 08/03/2021 answer text <p>Data on the percentage of patients admitted to hospital with COVID-19 and for other reasons is attached. Data is only available for England from August 2020 – January 2021.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 08/03/2021 15:17:57 question first ministerially corrected 08/03/2021 17:53:34 answering member 4362 label Biography information for Edward Argar attachment 1 file name PQ160659 - final data - Copy.xlsx title Admissions data 2020-2021 previous answer version 87907 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1276868

registered interest
date	14/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alzheimer's Disease and Multiple Sclerosis: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much money from the public purse has been allocated to research into (a) Parkinson's disease, (b) Alzheimers Disease and (c) Multiple Sclerosis in each of the last five years.
tabling member constituency	Walsall South
tabling member printed	Valerie Vaz
uin	137917
answer	answer is ministerial correction date of answer 26/01/2021 answer text <p>The Government is committed to supporting research into Parkinson's disease, Alzheimer’s disease and multiple sclerosis. The Department funds research into these areas through the National Institute for Health Research. Additionally, UK Research and Innovation funds research into these areas primarily through the Medical Research Council, the Biotechnology Biological Sciences Research Council, and the Economic and Social Research Council.</p><p>The attached table shows funding allocated through these routes, not including wider funding that contributes to research in these areas. Figures for research into Alzheimer’s disease are only part of overall dementia research spending.</p><p><ins class="ministerial">NIH</ins>R values refer to total spend. UKRI values refer to allocated / committed funding.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 26/01/2021 10:04:42 question first ministerially corrected 04/03/2021 10:12:02 answering member 4362 label Biography information for Edward Argar attachment 1 file name PQ 137917 table formatted.docx title Funding previous answer version 77042 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar attachment 1 file name PQ 137917 table formatted.docx title Funding
tabling member	4076 label Biography information for Valerie Vaz

1276302

registered interest
date	13/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kidney Diseases: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people traveling in Europe who require it will continue to be able to access kidney dialysis treatment free of charge, following the UK’s withdrawal from the European Health Insurance Card system.
tabling member constituency	Sheffield, Hallam
tabling member printed	Olivia Blake
uin	137347
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p><ins class="ministerial"> <p><ins class="ministerial">Following agreeing the Trade and Cooperation Agreement (TCA) with the European Union, United Kingdom residents travelling to the EU will continue to be covered for necessary healthcare, and this includes kidney dialysis. The new Global Health Insurance Card (GHIC) covers necessary healthcare for UK residents visiting the UK. UK residents can apply online for the GHIC. Current European Health Insurance Cards (EHIC) will remain valid until the expiration date.</ins></p><p><ins class="ministerial">Holders of current EHICs and the new GHIC are entitled to the same access to emergency and necessary healthcare cover when they travel to the EU, including cover for a pre-existing or chronic condition. In some countries, individuals may have to pay a percentage towards the cost of any state-provided treatment, known as a patient co-payment.</ins></p><p><ins class="ministerial">As before, UK residents will need to pre-arrange kidney dialysis with the relevant healthcare provider in the country they are visiting.</ins></p><p> </p></ins></p><p> </p><p><del class="ministerial">The reciprocal healthcare coverage under the United Kingdom-European Union Trade and Cooperation Agreement for those on a temporary stay in an EU member state is the same, in terms of healthcare services which can be accessed by individuals, compared to the previous coverage under EU Regulations 883 and 987. However, under the UK-EU Trade and Cooperation Agreement, crew or passengers of a vessel or aircraft may now be covered for necessary healthcare on their arrival in an EU member state if the need arose whilst on a voyage, which is not the case under the EU Regulations. </del></p> answering member constituency Charnwood answering member printed Edward Argar question first answered 18/01/2021 17:27:32 question first ministerially corrected 19/01/2021 12:08:22 answering member 4362 label Biography information for Edward Argar previous answer version 74905 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4864 label Biography information for Olivia Blake

1276338

registered interest
date	13/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Global Health Insurance Card
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the differences in coverage of (a) countries and (b) services are between the European Health Insurance Card scheme and the UK Global Health Insurance Card; and if he will make a statement.
tabling member constituency	Sheffield Central
tabling member printed	Paul Blomfield
uin	137184
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>The reciprocal healthcare coverage under the United Kingdom-European Union Trade and Cooperation Agreement for those on a temporary stay in an EU member state is the same, in terms of healthcare services which can be accessed by individuals, compared to the previous coverage under EU Regulations 883 and 987. However, under the UK-EU Trade and Cooperation Agreement, crew or passengers of a vessel or aircraft may now be covered for necessary healthcare on their arrival in an EU member state if the need arose whilst on a voyage, which is not the case under the EU Regulations.</p><p><ins class="ministerial">The UK-EU Trade and Cooperation Agreement provides reciprocal healthcare coverage for travel to EU member states only. European Free Trade Area states are not covered. The UK Global Health Insurance Card has been launched to recognise this new agreement and will gradually replace old European Health Insurance Cards (EHIC) once they expire. </ins></p><p><ins class="ministerial">Under the terms of the Withdrawal Agreement, UK nationals who were residing and/or working in the EU, and EU citizens residing and/or working in the UK, before 1 January 2021 are eligible to apply for a new UK EHIC which can be used for travel to EU member states, Switzerland, Norway, Iceland and Liechtenstein. For those who are not covered by the Withdrawal Agreement, the UK has agreed a bilateral reciprocal arrangement with Norway which means UK nationals are covered for necessary healthcare there.</ins></p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 18/01/2021 17:30:43 question first ministerially corrected 24/03/2021 11:09:28 answering member 4362 label Biography information for Edward Argar previous answer version 74914 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4058 label Biography information for Paul Blomfield

1244554

registered interest
date	19/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Noradrenaline
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the use of noradrenaline throughout the NHS in England in each month of 2020.
tabling member constituency	Peterborough
tabling member printed	Paul Bristow
uin	105571
answer	answer is ministerial correction date of answer 28/10/2020 answer text <p>NHS England and NHS Improvement undertake regular monitoring of the demand and supply position for priority medicines including noradrenaline. A table showing this information is attached.</p><p>We cannot make accurate projections of demand going forward. However, we have used the information regarding first wave usage to inform mitigations for a second wave, such as stockpiling.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 28/10/2020 16:09:55 question first ministerially corrected 11/11/2020 14:29:56 answering member 4362 label Biography information for Edward Argar attachment 1 file name 2020 10 22 PQs 105571-72 Bristow attachment.xlsx title Noradrenaline demand and supply previous answer version 57690 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4792 label Biography information for Paul Bristow

1244555

registered interest
date	19/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Noradrenaline
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an estimate of demand for noradrenaline during the remainder of 2020-21.
tabling member constituency	Peterborough
tabling member printed	Paul Bristow
uin	105572
answer	answer is ministerial correction date of answer 28/10/2020 answer text <p>NHS England and NHS Improvement undertake regular monitoring of the demand and supply position for priority medicines including noradrenaline. A table showing this information is attached.</p><p>We cannot make accurate projections of demand going forward. However, we have used the information regarding first wave usage to inform mitigations for a second wave, such as stockpiling.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 28/10/2020 16:09:55 question first ministerially corrected 11/11/2020 14:29:47 answering member 4362 label Biography information for Edward Argar attachment 1 file name 2020 10 22 PQs 105571-72 Bristow attachment.xlsx title Noradrenaline demand and supply previous answer version 57691 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4792 label Biography information for Paul Bristow